Physician profile
Amir Alavi
NPI 1619991296
$2,604.28
in general payments reported to CMS, 2019-2025
34 companies · $171 in 2025
The $171 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $383 · 2021: $813 · 2022: $332 · 2023: $330 · 2024: $116 · 2025: $171.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $616.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Collegium Pharmaceutical, INC. | $387.49 | 2019-2025 | Xtampza |
| Scilex Pharmaceuticals INC. | $312.62 | 2019-2023 | Ztlido |
| Medtronic, INC. | $163.69 | 2021 | |
| Abbott Laboratories | $153.95 | 2020-2025 | Octrode, Penta |
| Arbor Pharmaceuticals, INC. | $125.31 | 2019-2022 | |
| Forte Bio-Pharma LLC | $119.66 | 2019-2021 | |
| Almatica Pharma LLC | $116.88 | 2021-2022 | |
| Horizon Therapeutics Plc | $116.40 | 2020-2022 | |
| Stimwave Technologies Incorporated | $111.00 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $98.53 | 2021-2023 | Relistor |
| Novartis Pharmaceuticals Corporation | $97.65 | 2020-2021 | |
| Saluda Medical Americas, INC. | $92.20 | 2023 | Evoke Scs |
| Boston Scientific Corporation | $69.93 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Takeda Pharmaceuticals U.S.A., INC. | $66.13 | 2019-2020 | |
| Nevro Corp. | $62.34 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $59.42 | 2023-2025 | Exogen Ultrasound Bone Healing System, Supartz Fx Sodium Hyaluronate |
| Biodelivery Sciences International, INC. | $57.39 | 2020-2021 | |
| Spr Therapeutics, INC | $49.20 | 2019-2025 | Sprint Pns System |
| Valinor Pharma, LLC | $43.86 | 2023-2025 | Movantik |
| Nalu Medical, INC. | $41.86 | 2021 | |
| Medtronic USA, INC. | $34.40 | 2020 | |
| Azurity Pharmaceuticals, INC. | $33.15 | 2024 | Horizant |
| Kowa Pharmaceuticals America, INC. | $26.43 | 2022-2023 | Seglentis |
| Ermi LLC | $21.86 | 2019 | |
| Hikma Pharmaceuticals USA | $21.00 | 2022 | |
| Assertio Therapeutics, INC. | $18.72 | 2019 | |
| Redhill Biopharma INC. | $17.23 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $16.37 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $15.58 | 2025 | |
| Stryker Corporation | $14.79 | 2019 | |
| Pernix Therapeutics Holdings, INC. | $12.14 | 2019 | |
| Mdd US Operations, LLC | $11.73 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $11.55 | 2019 | |
| Currax Pharmaceuticals LLC | $3.82 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amir Alavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.